Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2023
July 26, 2022 at 07:00 am
Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and full year of fiscal year ending June 20, 2023. For the first half of fiscal 2023, the company expects net sales of Ã83,000 million, operating income of Ã2,900 million and net income attributable to owners of parent of Ã1,748 million and net Income per share of Ã115.13.
For the year ending June 20, 2023, the company expects net sales of Ã168,000 million, operating income of Ã5,800 million and net income attributable to owners of parent of Ã3,900 million net Income per share of Ã256.87.